Cooper University Health Care First in the Region to Implant the World's First Neuromodulation Device to Treat Symptoms of Heart Failure
March 30, 2023
March 30, 2023
CAMDEN, New Jersey, March 30 (TNSres) -- Cooper University Health Care issued the following news release on March 29, 2023:
Cooper University Health Care recently performed the region's first successful implant of Barostim(TM) Baroreflex Activation Therapy, the world's first FDA-approved heart failure device to use neuromodulation--the power of the brain and nervous system--to improve the symptoms of patients with systolic heart failure. This therapy was designed to treat heart fail . . .
Cooper University Health Care recently performed the region's first successful implant of Barostim(TM) Baroreflex Activation Therapy, the world's first FDA-approved heart failure device to use neuromodulation--the power of the brain and nervous system--to improve the symptoms of patients with systolic heart failure. This therapy was designed to treat heart fail . . .